Enzo Biochem, Inc.
ENZ was delisted on the 17th of April, 2025.
63 hedge funds and large institutions have $55.3M invested in Enzo Biochem, Inc. in 2014 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 13 increasing their positions, 14 reducing their positions, and 6 closing their positions.
217% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 6
59% more capital invested
Capital invested by funds: $34.8M → $55.3M (+$20.5M)
26% more funds holding
Funds holding: 50 → 63 (+13)
7% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 14
51% less call options, than puts
Call options by funds: $159K | Put options by funds: $325K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$3.61M |
| 2 |
EI
EAM Investors
Solana Beach,
California
|
+$1.77M |
| 3 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$1.59M |
| 4 |
PA
Perceptive Advisors
New York
|
+$1.3M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
+$1.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$6.62M |
| 2 |
Millennium Management
New York
|
-$778K |
| 3 |
Two Sigma Investments
New York
|
-$317K |
| 4 |
Morgan Stanley
New York
|
-$208K |
| 5 |
PRC
Platte River Capital
Denver,
Colorado
|
-$206K |
ENZ Hedge Fund Activity: Q1 2014 in Review
63 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem, Inc. (ENZ) for Q1 2014, worth a combined $55.3M — up 59% from $34.8M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new ENZ positions and 6 closed out — a net gain of 13 holders — while 13 added to existing stakes and 14 trimmed.
The largest buyer was First Light Asset Management, opening a new position worth an estimated $3.61M. The largest seller was RA Capital Management, exiting entirely with an estimated $6.62M sold.
- 63 institutional investors held Enzo Biochem, Inc. (ENZ) as of Q1 2014, up from 50 in Q4 2013.
- Funds reported $55.3M of Enzo Biochem, Inc. stock for Q1 2014, up 59% quarter-over-quarter.
- 19 funds opened new Enzo Biochem, Inc. positions in Q1 2014 and 6 closed out, a net change of +13 holders.
- The largest Enzo Biochem, Inc. buyer in Q1 2014 was First Light Asset Management, an estimated $3.61M added.
- The largest Enzo Biochem, Inc. seller in Q1 2014 was RA Capital Management, an estimated $6.62M sold.
Based on aggregated 13F filings for Q1 2014.